1.
AB0425 Real-world effectiveness of Filgotinib in belgian patients with rheumatoid arthritis
2.
3.
4.
THU0200 THE CHOICE OF BDMARD OR TSDMARD AS FIRST LINE THERAPY: DATA OF THE TARDIS-RA REGISTRY, A NATIONWIDE BELGIAN BIOLOGIC REGISTRY
POS1203 EFFECT OF THE COVID19 PANDEMIC ON RHEUMATOLOGIST PRESCRIPTION BEHAVIOUR OF NEW ADVANCED THERAPY: DATA OF THE TARDIS-RA REGISTRY, A NATIONWIDE BELGIAN BIOLOGIC REGISTRY
HLA class II and T-cell receptor beta chain polymorphisms in Belgian patients with rheumatoid arthritis: no evidence for disease association with the TCRBC2, TCRBV8 and TCRBV11 pol...
AB0758 REAL-WORLD EFFICACY AND SAFETY OF APREMILAST IN BELGIAN PATIENTS WITH PSORIATIC ARTHRITIS: FINAL ANALYSIS OF THE MULTICENTRE, PROSPECTIVE APOLO STUDY
From Belgium
Systemic lupus erythematosus on the Caribbean island of Curacao: an epidemiological investigation.
Determinants of direct costs in Dutch rheumatoid arthritis patients
Epidemiological study of HLA and GM in rheumatoid arthritis and related symptoms in an open Dutch population.
HLA-B27 associated reactive spondyloarthropathies in a Dutch military hospital.